IMVT
Immunovant, Inc. · Healthcare
CEO Peter Salzmann sold $130K of Immunovant, Inc.
Sold$129,609
$28.06Price
4,619Shares
What IMVT did after the filing
- The stock from Wed, Jul 10 close, $30.35
- +7.0%
- S&P 500, same days
- −0.1%
Measured over 30 trading days, to the Aug 21 close.
Traded Tue, Jul 9. Filed Wed, Jul 10, 1:04 PM ET, during the session. Returns use the Jul 10 close and the Aug 21 close. Not investment advice.